Name | arg-gly-asp |
Synonyms | H2N-RGD-OH arg-gly-asp ARG-GLY-ASP L-ARG-GLY-ASP H-ARG-GLY-ASP-OH Arg-Gly-Asp acetate ARG-GLY-ASP PEPTIDE Arginyl-glycyl-asparagilin ARGINYL-GLYCYL-ASPARTIC ACID |
CAS | 99896-85-2 |
InChI | InChI=1/C12H22N6O6/c13-4-6(19)12(17,10(23)24)7(9(21)22)8(20)5(14)2-1-3-18-11(15)16/h5,7H,1-4,13-14,17H2,(H,21,22)(H,23,24)(H4,15,16,18) |
InChIKey | IYMAXBFPHPZYIK-BQBZGAKWSA-N |
Molecular Formula | C12H22N6O6 |
Molar Mass | 346.34 |
Density | 1.61±0.1 g/cm3(Predicted) |
Melting Point | 153-155℃ (ethyl ether ) |
Boling Point | 597.205°C at 760 mmHg |
Flash Point | 314.979°C |
Solubility | Soluble in 0.1N acetic acid at 20mg/ml |
Vapor Presure | 0mmHg at 25°C |
Appearance | Powder |
pKa | 2.85±0.10(Predicted) |
Storage Condition | -20°C |
Sensitive | Easily absorbing moisture |
Refractive Index | 1.671 |
MDL | MFCD00057952 |
Use | Preferred sequence involving binding to cell surface proteins |
In vitro study | RGD is the most effective and most often employed peptide sequence for stimulated cell adhesion on synthetic surfaces. There are 24 integrins binding to ECM molecules in a RGD dependent manner: α3β1, α5β1, α8β1, αIIbβ3, αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, and to some extent α2β1 and α4β1. |
WGK Germany | 3 |
biological activity | RGD is a tripeptide that can effectively cause cell adhesion, localizing a specific cell line and generating a specific cellular response; Capable of binding to integrins. |
Target | Integrin |